Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Prakash Chinnaiyan, MD
William Beaumont Hospital and Oakland University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ottawa Hospital Regional Cancer Centre - General Campus
Ottawa, Ontario, Canada
- Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- University of Florida Shands Cancer Center
Gainesville, Florida, United States
- Baptist Cancer Institute - Jacksonville
Jacksonville, Florida, United States
- Baptist Medical Center South
Jacksonville, Florida, United States
- Integrated Community Oncology Network at Southside Cancer Center
Jacksonville, Florida, United States
- Integrated Community Oncology Network
Jacksonville Beach, Florida, United States
- Integrated Community Oncology Network - Orange Park
Orange Park, Florida, United States
- Florida Cancer Center - Palatka
Palatka, Florida, United States
- Flagler Cancer Center
Saint Augustine, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- St. Vincent Oncology Center
Indianapolis, Indiana, United States
- St. Agnes Hospital Cancer Center
Baltimore, Maryland, United States
- Dana-Farber/brigham and Women'S Cancer Center
Boston, Massachusetts, United States
- Regional Cancer Center at Singing River Hospital
Pascagoula, Mississippi, United States
- St. Barnabas Medical Center Cancer Center
Livingston, New Jersey, United States
- New York Oncology Hematology, Pc at Albany Regional Cancer Care
Albany, New York, United States
- James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, United States
- University Radiation Oncology at Parkridge Hospital
Rochester, New York, United States
- Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, United States
- Summa Center for Cancer Care at Akron City Hospital
Akron, Ohio, United States
- Barberton Citizens Hospital
Barberton, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Willamette Valley Cancer Center - Eugene
Eugene, Oregon, United States
- Adams Cancer Center
Gettysburg, Pennsylvania, United States
- Cherry Tree Cancer Center
Hanover, Pennsylvania, United States
- Mcglinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania, United States
- York Cancer Center at Apple Hill Medical Center
York, Pennsylvania, United States
- Rhode Island Hospital Comprehensive Cancer Center
Providence, Rhode Island, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- Tyler Cancer Center
Tyler, Texas, United States
- Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah, United States
- Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin, United States
- Waukesha Memorial Hospital Regional Cancer Center
Waukesha, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 30 Jun 2016
- Completion
- 20 May 2022
- Last update posted
- 9 Jun 2022
- Registered enrollment
- 279
- Registry id
- NCT01062399
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.